What this page clarifies
- Defines pluripotency without implying an approved therapy.
- Explains mature-cell reprogramming and why source disclosure still matters.
- Separates education, research models, clinical trials, and established care.
Questions to ask before moving forward
- What cell type was used to begin the workflow?
- Is the provider discussing research, a trial, or approved care?
- Which claims are supported by published evidence and which are not yet established?
Recommended pathway
- Begin with a family-friendly glossary.
- Collect diagnosis and clinical context.
- Prepare questions for a licensed physician or trial team.